The UK's largest retail investment manager, Invesco Perpetual, has been fined £18.6 million by the Financial Conduct Authority (FCA) for exposing investors to greater levels of risk than they expected.
US drugs giant Pfizer has publicly admitted it made a £58.7 billion bid for UK rival AstraZeneca in January, which the UK firm rejected, but it is attempting again, sweet talking direct to Astra's shareholders in an overture th
Investors in small and mid-cap investment trusts should consider taking profits following a strong period of performance and signs that the market is beginning to pull back, says broker Oriel Securities.
AstraZeneca chief executive Pascal Soriot gave an upbeat account of the company's 'rapidly progressing' innovation pipeline as he sought to shift focus back to his turnround efforts after days of speculation about a takeover by
GlaxoSmithKline announced a transformational three-part transaction with Swiss pharma Novartis on Tuesday which will see shareholders receive a £4 billion capital return funded by net cash transaction proceeds, expected to be d